Loading...
908 Devices Inc.
MASS•NASDAQ
Healthcare
Medical - Devices
$7.42
$0.04(0.54%)
908 Devices Inc. (MASS) Financial Performance & Income Statement Overview
Review 908 Devices Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
18.72%
↑ 18.72%
Operating Income Growth
-79.42%
↓ 79.42%
Net Income Growth
-98.37%
↓ 98.37%
Operating Cash Flow Growth
-20.70%
↓ 20.70%
Operating Margin
-122.21%
↓ 122.21%
Gross Margin
49.49%
↑ 49.49%
Net Profit Margin
-28.80%
↓ 28.80%
ROE
-12.60%
↓ 12.60%
ROIC
-42.53%
↓ 42.53%
908 Devices Inc. (MASS) Income Statement & Financial Overview
Review 908 Devices Inc.'s (MASS) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $18.82M | $16.77M | $14.05M | $9.99M |
| Cost of Revenue | $9.72M | $8.44M | $6.63M | $6.10M |
| Gross Profit | $9.10M | $8.33M | $7.42M | $3.90M |
| Gross Profit Ratio | $0.48 | $0.50 | $0.53 | $0.39 |
| R&D Expenses | $6.54M | $6.79M | $6.38M | $4.79M |
| SG&A Expenses | $13.76M | $13.38M | $14.60M | $11.79M |
| Operating Expenses | $29.36M | $38.55M | $20.98M | $16.58M |
| Total Costs & Expenses | $39.07M | $46.99M | $27.61M | $22.68M |
| Interest Income | $753000.00 | $879000.00 | $1.13M | $1.73M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $1.44M | $1.41M | $693000.00 | $1.33M |
| EBITDA | -$18.08M | -$27.95M | -$11.92M | -$9.66M |
| EBITDA Ratio | -$0.96 | -$1.67 | -$0.85 | -$0.97 |
| Operating Income | -$20.25M | -$30.22M | -$13.56M | -$12.69M |
| Operating Income Ratio | -$1.08 | -$1.80 | -$0.97 | -$1.27 |
| Other Income/Expenses (Net) | $736000.00 | $850000.00 | $943000.00 | $1.70M |
| Income Before Tax | -$19.52M | -$29.37M | -$12.62M | -$10.99M |
| Income Before Tax Ratio | -$1.04 | -$1.75 | -$0.90 | -$1.10 |
| Income Tax Expense | -$71000.00 | -$72000.00 | -$69000.00 | -$70000.00 |
| Net Income | -$19.45M | -$29.30M | -$12.55M | -$10.92M |
| Net Income Ratio | -$1.03 | -$1.75 | -$0.89 | -$1.09 |
| EPS | -$0.57 | -$0.84 | -$0.37 | -$0.33 |
| Diluted EPS | -$0.57 | -$0.84 | -$0.37 | -$0.33 |
| Weighted Avg Shares Outstanding | $34.67M | $34.67M | $34.06M | $32.71M |
| Weighted Avg Shares Outstanding (Diluted) | $34.67M | $34.67M | $34.06M | $32.71M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan